Outcomes of Children and Adolescents Admitted with Diabetic Ketoacidosis at Kenyatta National Hospital (KNH), Kenya

Copyright © 2020 Sophie Nyaombe Musoma et al..

BACKGROUND: Diabetic ketoacidosis (DKA) is an acute, major, life-threatening complication that mainly occurs in patients with type 1 diabetes mellitus and is the foremost cause of death in these children. Overall mortality in children with DKA varies from 3.4% to 13.4% in developing countries. There is a need to understand outcomes among children with DKA in sub-Saharan African countries.

OBJECTIVE: To determine the death rate and clinical outcomes of children and adolescents aged 0-18 years managed for DKA at Kenyatta National Hospital (KNH). Study Methods. This was a retrospective study carried out among children aged 0-18 years admitted with DKA at KNH between February 2013 and February 2018. The study site was the central records department at KNH. The inclusion criteria were children aged 0-18 years admitted with a diagnosis of DKA based on the ISPAD guidelines biochemical criteria.

RESULTS: Out of the 159 files reviewed, the median age of children was 13 years (IQR 10-15). 41.1% of patients had severe DKA while 35.7% had moderate DKA. We reported a mortality of 6.9% while 93.1% of children recovered and were discharged home. The median duration of hospital stay was 8 days. High risk of mortality was reported among children who had high serum creatinine (OR 5.8 (95% CI 1.6-21.2)), decreased urine output (OR 9.0 (95% CI 2.2-37.3)), and altered level of consciousness (OR 5.2 (95% CI 1.1-25.1)).

CONCLUSION: DKA-associated mortality in our study was low at 6.9%. High serum creatinine, decreased urine output, and altered level of consciousness were associated with a significantly higher risk of mortality.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:2020

Enthalten in:

Journal of diabetes research - 2020(2020) vom: 21., Seite 8987403

Sprache:

Englisch

Beteiligte Personen:

Musoma, Sophie Nyaombe [VerfasserIn]
Omar, Anjumanara [VerfasserIn]
Mutai, Beatrice Chepngeno [VerfasserIn]
Laigong, Paul [VerfasserIn]

Links:

Volltext

Themen:

AYI8EX34EU
Blood Glucose
Creatinine
Journal Article
Observational Study

Anmerkungen:

Date Completed 27.09.2021

Date Revised 18.04.2022

published: Electronic-eCollection

Citation Status MEDLINE

doi:

10.1155/2020/8987403

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM317028014